Search results for "Necrosis"

showing 10 items of 1354 documents

The Addition of an Immunosuppressant After Loss of Response to Anti-TNFα Monotherapy in Inflammatory Bowel Disease: A 2-Year Study

2018

Background The addition of an immunosuppressant (IM) after loss of response to anti-TNFα monotherapy is an emerging strategy of therapeutic optimization in patients with inflammatory bowel disease (IBD). However, few clinical data have been reported to date. We aimed to evaluate the efficacy and safety of this selective combination therapy in patients with IBD. Methods All consecutive patients with loss of response to anti-TNFα monotherapy despite an intensive dose optimization who added an IM from October 2014 to October 2016 were entered into a prospective database. Results Among 630 patients treated with anti-TNFα agents during the study period, 46 (7.3%) added an IM. A total of 31 patie…

AdultMalemedicine.medical_specialtyDatabases FactualCombination therapyGastroenterologyInflammatory bowel diseaseDrug Administration Schedule03 medical and health sciences0302 clinical medicineInternal medicinemedicineAdalimumabHumansImmunology and AllergyProspective StudiesAdverse effectbiologyTumor Necrosis Factor-alphabusiness.industryRemission InductionC-reactive proteinAdalimumabGastroenterologyAntibodies MonoclonalMiddle AgedInflammatory Bowel Diseasesmedicine.diseaseInfliximabGolimumabInfliximabDiscontinuationC-Reactive ProteinTreatment Outcome030220 oncology & carcinogenesisbiology.proteinDrug Therapy CombinationFemale030211 gastroenterology & hepatologybusinessImmunosuppressive Agentsmedicine.drugInflammatory Bowel Diseases
researchProduct

Surgery during etanercept therapy in patients with rheumatoid arthritis: is it time to follow patient preferences?

2008

Tumor necrosis factor (TNF)-a inhibitors, such as etanercept and infliximab, improve symptoms and function in patients affected by rheumatoid arthritis (RA) [1, 2] and, therefore, are playing an increasing role in the management of this disease. However, interference with endogenous TNF-a signalling has been reported to alter both normal inflammatory responses in tissue healing and infection surveillance [2, 3]. To our knowledge, the rates of surgery in RA are decreasing. However, with the duration of antiTNF therapy, the number of patients under these agents having surgery will be increasing. These data raise the question of whether TNF-inhibitors can be safely used in RA patients who shou…

AdultMalemedicine.medical_specialtyDiseaseReceptors Tumor Necrosis FactorEtanerceptEtanerceptArthritis RheumatoidPostoperative ComplicationsInternal MedicinemedicineOutpatient clinicHumansElective surgeryWound Healingbusiness.industryContraindicationsAnti-Inflammatory Agents Non-SteroidalMiddle Agedmedicine.diseaseInfliximabSurgeryItalyPatient SatisfactionRheumatoid arthritisImmunoglobulin GSurgical Procedures OperativeCohortEmergency MedicineQuality of LifeMethotrexateFemalebusinessmedicine.drugInternal and emergency medicine
researchProduct

Mycophenolate mofetil is a valid option in patients with inflammatory bowel disease resistant to TNF-α inhibitors and conventional immunosuppressants.

2017

Abstract Background Few studies investigated the role of mycophenolate mofetil in inflammatory bowel disease, and none of them had specifically focused on patients with previous multiple intolerances and/or nonresponses to conventional immunosuppressants and biologics. Aims To evaluate clinical benefit and tolerability profile of mycophenolate mofetil in patients with inflammatory bowel disease and limited treatment options. Methods All consecutive patients with previous multiple intolerances and/or nonresponses to immunosuppressants and biologics who started an off-label treatment with mycophenolate mofetil from January 2014 to February 2016 were entered in a prospectively maintained datab…

AdultMalemedicine.medical_specialtyDrug ResistanceKaplan-Meier EstimateMycophenolateInflammatory bowel diseaseGastroenterology03 medical and health sciencesYoung Adult0302 clinical medicineIntolerancesInternal medicineMedicineHumansIn patientEnzyme InhibitorsAgedCrohn's diseaseBiological ProductsHepatologybusiness.industryTumor Necrosis Factor-alphaGastroenterologyMiddle AgedMycophenolic Acidmedicine.diseaseInflammatory Bowel DiseasesUlcerative colitisDiscontinuationTreatment OutcomeTolerabilityItaly030220 oncology & carcinogenesisImmunology030211 gastroenterology & hepatologyFemalebusinessImmunosuppressive AgentsDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
researchProduct

Effects of Pentoxifylline on Soluble Klotho Concentrations and Renal Tubular Cell Expression in Diabetic Kidney Disease

2018

OBJECTIVE The effect of pentoxifylline on Klotho levels in patients with type 2 diabetes mellitus with chronic kidney disease (CKD) was assessed in a post hoc analysis of the Pentoxifylline for Renoprotection in Diabetic Nephropathy (PREDIAN) trial. RESEARCH DESIGN AND METHODS Circulating and urinary tumor necrosis factor-α (TNF-α) and Klotho were measured before and after 1 year of pentoxifylline. The effect on Klotho expression was assessed in cultured renal tubular cells. RESULTS Pentoxifylline administration resulted in decreased serum and urinary TNF-α, whereas serum and urinary Klotho increased significantly. Changes in urinary Klotho, urinary TNF-α, and phosphorus were associated wi…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and MetabolismUrinary system030232 urology & nephrologyRenal function030204 cardiovascular system & hematologyKidneyurologic and male genital diseasesPentoxifyllineDiabetic nephropathyMice03 medical and health sciences0302 clinical medicineInternal medicineInternal MedicineAlbuminuriaAnimalsHumansMedicineDiabetic NephropathiesPentoxifyllineRenal Insufficiency ChronicKlotho ProteinsKlothoCells CulturedAgedGlucuronidaseAdvanced and Specialized NursingTumor Necrosis Factor-alphabusiness.industryKidney metabolismMiddle Agedmedicine.diseasefemale genital diseases and pregnancy complicationsKidney TubulesEndocrinologyDiabetes Mellitus Type 2AlbuminuriaFemalemedicine.symptombusinessFollow-Up StudiesGlomerular Filtration RateKidney diseasemedicine.drugDiabetes Care
researchProduct

Effects of red orange juice intake on endothelial function and inflammatory markers in adult subjects with increased cardiovascular risk

2012

BACKGROUND Oxidative and inflammatory stresses are involved in the pathogenesis of atherosclerosis. The consumption of fruit and vegetables is associated with improved health and reduced cardiovascular risk. Red oranges have a high content of antioxidant and antiinflammatory substances, but there is a paucity of data concerning their effects on cardiovascular biomarkers in subjects with increased cardiovascular risk. OBJECTIVE We investigated the effect of red orange juice intake on endothelial function, oxidative stress, and markers of inflammation in subjects with increased cardiovascular risk. DESIGN Nineteen nondiabetic subjects with increased cardiovascular risk (aged 27-56 y) were inc…

AdultMalemedicine.medical_specialtyEndotheliumAnti-Inflammatory AgentsMedicine (miscellaneous)Inflammationmedicine.disease_causePlaceboAntioxidantsBeveragesYoung AdultRisk FactorsInternal medicineDiabetes mellitusDiabetes MellitusmedicineBody Fat DistributionHumansSingle-Blind MethodEndotheliumSettore MED/49 - Scienze Tecniche Dietetiche Applicateendothelial function cardiovascular risk red oranges inflammation FMDAgedInflammationOrange juiceCross-Over StudiesNutrition and DieteticsbiologyInterleukin-6Tumor Necrosis Factor-alphabusiness.industryC-reactive proteinMiddle Agedmedicine.diseaseCrossover studyOxidative StressC-Reactive ProteinEndocrinologymedicine.anatomical_structureCardiovascular DiseasesFruitbiology.proteinFemalemedicine.symptombusinessBiomarkersOxidative stressCitrus sinensis
researchProduct

Testosterone administration increases leukocyte-endothelium interactions and inflammation in transgender men

2021

Objective To evaluate the effect of testosterone treatment on metabolic and inflammation parameters and leukocyte-endothelium interactions in transgender men (TGM). Design Prospective observational study. Setting University hospital. Patient(s) One hundred fifty-seven TGM. Intervention(s) Administration of testosterone undecanoate (1,000 mg, intramuscular) every 12 weeks. Main Outcome Measure(s) Endocrine parameters, adhesion molecules (vascular cell adhesion molecule-1, intercellular cell adhesion molecule-1, and E-selectin), proinflammatory cytokines interleukin-6, and tumor necrosis factor alpha were evaluated in serum before and after treatment using Luminex’s xMAP technology. In additi…

AdultMalemedicine.medical_specialtyEndotheliumInjections Subcutaneousmedicine.medical_treatmentInflammationTransgender PersonsProinflammatory cytokineYoung AdultInternal medicineHuman Umbilical Vein Endothelial CellsLeukocytesHumansMedicineTestosteroneProspective StudiesCell adhesionCells CulturedTestosteroneInflammationbusiness.industryCell adhesion moleculeObstetrics and Gynecologymedicine.anatomical_structureCytokineEndocrinologyReproductive MedicineAndrogensTumor necrosis factor alphaEndothelium VascularInflammation Mediatorsmedicine.symptombusinessCell Adhesion MoleculesFertility and Sterility
researchProduct

Indications and limitations of the fixator TGF “Gex-Fix” in proximal end humeral fractures

2014

Abstract The incidence of fractures of the humerus has increased exponentially in recent years. The most used classifications for humerus fracture are morphological (Neer), biological (AO/ASIF) and descriptive (Hertel). The types of surgical treatment for humerus fracture include prosthetic replacement and synthesis using different devices, including the Tension Guide Fixator (TGF), Gex-Fix. External fixation for displaced proximal humeral fractures avoids dissection and soft tissue stripping and has been reported by some authors to be associated with higher union rates, a lower incidence of avascular necrosis, less scarring of the scapulohumeral interface, and faster rehabilitation compare…

AdultMalemedicine.medical_specialtyExternal FixatorsCost-Benefit Analysismedicine.medical_treatmentHumerus fractureOsteoporosisHumeruAvascular necrosisExternal fixationFracture FixationSettore MED/33 - Malattie Apparato LocomotoremedicineHumansOutpatient clinicInternal fixationHumerusAgedGeneral Environmental ScienceAged 80 and overExternal fixatorbusiness.industryPatient SelectionSynthesiSoft tissueEquipment DesignMiddle Agedmedicine.diseaseTGFSurgeryTreatment OutcomeFracturemedicine.anatomical_structureHumeral HeadShoulder FracturesGeneral Earth and Planetary SciencesFemalebusinessLearning CurveBone WiresFollow-Up StudiesInjury
researchProduct

Inflammation, genetics, and longevity: further studies on the protective effects in men of IL-10 -1082 promoter SNP and its interaction with TNF-alph…

2003

Ageing is associated with chronic, low grade inflammatory activity leading to long term tissue damage, and systemic chronic inflammation has been found to be related to mortality risk from all causes in older persons.1 Also, the genetic constitution of the organism interacting with systemic inflammation may cause defined organ specific illnesses. Thus, age related diseases such as Alzheimer’s disease (AD), Parkinson’s disease, atherosclerosis, type 2 diabetes, sarcopenia, and osteoporosis, are initiated or worsened by systemic inflammation, suggesting the critical importance of unregulated systemic inflammation in the shortening of survival in humans.1–3 Accordingly, proinflammatory cytokin…

AdultMalemedicine.medical_specialtyGenotypemedicine.medical_treatmentDNA Mutational AnalysisLongevityInflammationSingle-nucleotide polymorphismBiologySystemic inflammationPolymorphism Single NucleotideProinflammatory cytokineGene FrequencyInternal medicineGeneticsmedicineHumansAllelePromoter Regions GeneticGenetics (clinical)AgedGeneticsAged 80 and overInflammationTumor Necrosis Factor-alphaAge FactorsDNAMiddle AgedInterleukin-10Interleukin 10CytokineEndocrinologyImmunologyFemalemedicine.symptomCentenarianLetter to JMGJournal of medical genetics
researchProduct

A genetically determined high setting of TNF-alpha influences immunologic parameters of HLA-B8,DR3 positive subjects: implications for autoimmunity.

2001

The 8.1 ancestral haplotype (AH) is a common Caucasoid haplotype carried by most people who type for HLA-B8,DR3. It seems unique in its association with a wide range of immunopathologic diseases. Healthy subjects bearing this haplotype demonstrate several alterations of immune response. This article will focus on the identification of the mechanism(s) of disease susceptibility of 8.1 AH. In 13 carriers of 8.1 AH, and 43 negative patients, enzyme immune assays serum levels of tumor necrosis factor (TNF)-alpha, soluble endothelial leukocyte adhesion molecule-1 (sELAM-1), cortisol, and interleukin(IL)-10 were determined. In addition, quantification of cytokine produced in vitro after mitogen s…

AdultMalemedicine.medical_specialtyHydrocortisonemedicine.medical_treatmentImmunologyHLA-DR3Biologymedicine.disease_causeAutoimmunityAutoimmune DiseasesHLA-B8 AntigenImmune systemHLA-DR3 AntigenInternal medicinemedicineImmunology and AllergyHumansGenetic Predisposition to DiseaseCells CulturedTumor Necrosis Factor-alphaHaplotypeInterleukinGeneral MedicineMiddle AgedInterleukin-10Interleukin 10EndocrinologyCytokineHaplotypesImmunologyTumor necrosis factor alphaFemaleE-SelectinHuman immunology
researchProduct

Myocardial scarring by delayed enhancement cardiovascular magnetic resonance in thalassaemia major

2009

Background: Cardiovascular magnetic resonance (CMR) by delayed enhancement (DE) enables visualisation of myocardial scarring, but no dedicated studies are available in thalassaemia major. Objective: To investigate the prevalence, extent, clinical and instrumental correlates of myocardial fibrosis or necrosis by DE CMR in patients with thalassaemia major. Patients: 115 Patients with thalassaemia major consecutively examined at an MRI laboratory. Methods: DE images were acquired to quantify myocardial scarring. Myocardial iron overload was determined by multislice multiecho T2*. Cine images were obtained to evaluate biventricular function. Results: DE areas were present in 28/115 patients (24…

AdultMalemedicine.medical_specialtyIron Overloadthalassaemia majorThalassemiaMagnetic Resonance Imaging CineCicatrixNecrosisFibrosisInternal medicineMyocardial scarringmedicineHumansMultisliceRetrospective Studiesmedicine.diagnostic_testbusiness.industryMyocardiumbeta-ThalassemiaMagnetic resonance imagingRetrospective cohort studymedicine.diseaseHemoglobinopathyCardiologyFemaleMyocardial fibrosismedicine.symptomCardiology and Cardiovascular MedicineNuclear medicinebusinessMagnetic Resonance AngiographyMyocardial scarring
researchProduct